Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 399 entries
View as:

Bathing Bundle Regimen in Reducing Gynecological Surgical Site Infection in Patients Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01597804 Org: User:
Start: 04/30/11 End: 04/30/16 Due: 04/30/17

Radiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00891904 Org: User:
Start: 04/30/09 End: - Due: -

Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03691376 Org: User:
Start: 03/08/19 End: 06/24/24 Due: 06/24/25

Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04067830 Org: User:
Start: 03/20/19 End: 03/22/26 Due: 03/22/27

A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts

Phase: N/A Priority: Normal
NCT ID: NCT01007552 Org: User:
Start: 12/31/09 End: 05/31/15 Due: 05/31/16

Sleep and Circadian Rhythm Study in Head and Neck Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT05099952 Org: User:
Start: 12/15/21 End: 12/15/26 Due: 12/15/27

Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT03880422 Org: User:
Start: 05/02/19 End: 05/02/29 Due: 05/02/30

Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03735589 Org: User:
Start: 12/15/23 End: 12/01/25 Due: 12/01/26

Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01649791 Org: User:
Start: 01/31/10 End: 10/31/14 Due: 10/31/15

Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05741164 Org: User:
Start: 10/22/24 End: 12/15/27 Due: 12/15/28

Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03333486 Org: User:
Start: 12/07/17 End: 08/28/24 Due: 08/28/25

Ofatumumab and Bortezomib in Treating Patients With Previously Untreated Waldenstrom Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT01536067 Org: User:
Start: 04/30/12 End: - Due: -

Fulvestrant in Treating Patients With Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00244998 Org: User:
Start: 09/30/05 End: 06/30/12 Due: 06/30/13

An Alternative Dosing Schedule of Varenicline for Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00835900 Org: User:
Start: 03/31/09 End: 07/31/15 Due: 07/31/16

Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01682031 Org: User:
Start: 06/30/09 End: 06/30/12 Due: 06/30/13

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02575508 Org: User:
Start: - End: - Due: -

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00003894 Org: User:
Start: 03/31/99 End: 06/30/02 Due: 06/30/03

A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York

Phase: N/A Priority: Normal
NCT ID: NCT06833255 Org: User:
Start: 07/30/25 End: 03/30/30 Due: 03/30/31

Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00625183 Org: User:
Start: 03/31/08 End: 12/31/09 Due: 12/31/10

Icotinib Hydrochloride in Treating Patients With Advanced Cancers

Phase: N/A Priority: Normal
NCT ID: NCT02033148 Org: User:
Start: 08/31/14 End: - Due: -

A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05138900 Org: User:
Start: 12/16/21 End: 03/09/28 Due: 03/09/29

Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02072486 Org: User:
Start: 11/18/13 End: 07/19/20 Due: 07/19/21

Quality of Life Intervention to Inform Patient Decision-Making in Early-Stage Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05292521 Org: User:
Start: 12/21/23 End: 06/15/25 Due: 06/15/26

Study of Photodynamic Therapy (PDT) Using HPPH in Barrett's Esophagus

Phase: N/A Priority: Normal
NCT ID: NCT01236443 Org: User:
Start: 08/31/00 End: 04/30/13 Due: 04/30/14

Decitabine/Cedazuridine and Enzalutamide for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05037500 Org: User:
Start: 01/26/22 End: 01/03/25 Due: 01/03/26